Companies: 10,795·Total market cap: $144.5T
Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATHENASDAQHealthcare● Active
$3.92
+$0.02(+0.46%)
Market Cap$35534263
P/E Ratio
52W High$7
52W Low$2.66

Alterity Therapeutics Limited(ATHE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ATHE · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$5.44M$4.02M$3.92M$5.12M$4.34M
Cost of Revenue$0.13M$0.21M$0.29M$0.36M$0.36M
Gross Profit$5.31M$3.80M$3.63M$4.76M$3.98M
Gross Margin %(computed)97.66%94.67%92.72%92.88%91.70%
Operating Expenses
R&D Expenses$14.40M$18.64M$13.20M$14.75M$12.28M
G&A Expenses$5.48M$4.77M$4.99M$5.43M$6.85M
Total Operating Expenses$19.89M$23.41M$18.24M$20.26M$19.16M
Operating Income($14.57M)($19.60M)($14.64M)($15.50M)($15.18M)
Operating Margin %(computed)-267.96%-487.69%-373.72%-302.56%-349.77%
Interest Income$0.45M$0.27M$0.02M$0.00M$0.02M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($12.08M)($19.08M)($13.70M)($12.78M)($15.31M)
Income Tax Expense$0.07M$0.05M$0.10M$0.07M$0.00M
Net Income($12.15M)($19.12M)($13.81M)($12.85M)($15.31M)
Net Margin %(computed)-223.35%-475.79%-352.54%-250.75%-352.78%
Per Share & EBITDA
EPS (Basic)$-1.14$-3.12$-3.42$-3.18$-5.40
Wtd Avg Shares10.66M6.08M4.05M4.01M2.83M
EBITDA($14.63M)($19.57M)($14.60M)($17.39M)($15.16M)
EBITDA Margin %(computed)-269.05%-486.94%-372.75%-339.46%-349.34%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解Alterity Therapeutics Limited

关于Alterity Therapeutics Limited(ATHE)损益表

Alterity Therapeutics Limited(ATHE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ATHE实现营收$0.01B,毛利润$0.01B(毛利率97.66%),净利润($0.01B)(净利率-223.35%)。

常见问题

ATHE · 4 问

Alterity Therapeutics Limited(ATHE)2025财年营收为$0.01B,同比up35.3%。

ATHE revenueATHE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09